The popularity of copyright’s blockbuster initially drove a boom for pharma, however recent changes present a uncertain outlook for those considering a stake. Generic versions are eating into profits, and continued https://harmonygysn058615.ltfblog.com/39648273/the-blue-pill-and-pharma-a-risky-bet